Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
509079 | BSE
1.20
0.37%
Healthcare
Drugs - Generic
31/03/2023
08/12/2023
327.10
326.80
331.55
323.60
Gufic Biosciences Limited engages in the manufacture and marketing of active pharmaceutical ingredients (APIs) generic pharmaceuticals and related services in India. It manufactures APIs and bulk drugs such as antifungals anaesthetics and immuno suppressants as well as intermediates for antifungals. The company also manufactures lyophilized injections which include antibiotic antifungal cardiac infertility antiviral and proton-pump inhibitor segments. In addition it offers spark criti care and ferticare pharmaceutical products; and herbal and personal care products. The company supplies its products to hospital chains and medical facilities. It also exports its products. The company was founded in 1970 and is based in Mumbai India.
View LessPositive Momentum
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
High Short-term Volatility
Microcap (<300M USD)
Weak P/E, and PEG ratio indicator
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Rich in Valuation (Price to Book > 8)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
65.1%1 month
60.8%3 months
46.3%6 months
50.7%77.09
0
9.89
1.48
0.60
28.06
3.33
0
451.83M
7.00B
83.93M
0.04
10.98
281.80
42.50
25.22
0
0
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
52.75
Range1M
91.25
Range3M
110.10
Rel. volume
0.42
Price X volume
3.94M